# Market Potential of Carbon Dioxide Nasal Spray

> **NCT02113449** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 147 (actual)

## Conditions studied

- Nasal Congestion

## Interventions

- **DRUG:** Carbon Dioxide

## Key facts

- **NCT ID:** NCT02113449
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02113449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02113449, "Market Potential of Carbon Dioxide Nasal Spray". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02113449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*